| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $534.6M | — | +11.0% |
| Cost of Revenue | $262.3M | — | +10.0% |
| Gross Profit | $272.3M | — | +11.9% |
| R&D Expense | $43.7M | — | +5.8% |
| SG&A Expense | $160.5M | — | +25.1% |
| Operating Income | $68.1M | — | -7.7% |
| Pre-tax Income | $52.9M | — | -27.8% |
| Income Tax | $8.7M | — | -7.4% |
| Net Income | $44.2M | — | -30.8% |
| EPS (Basic) | $0.39 | — | -31.6% |
| EPS (Diluted) | $0.39 | — | -31.6% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $268.0M | -15.9% | — |
| Accounts Receivable | $277.2M | -2.8% | — |
| Inventory | $321.3M | +6.5% | — |
| Current Assets | $929.5M | -4.8% | — |
| Total Assets | $3.70B | -3.3% | — |
| Current Liabilities | $579.0M | -50.1% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19.1M | — | -73.5% |
| Capital Expenditures | $8.7M | — | +55.4% |
| Investing Cash Flow | -$8.7M | — | -112.2% |
| Financing Cash Flow | -$59.1M | — | +18.6% |
| Free Cash Flow | $10.4M | — | -84.3% |
| Long-term Debt | $1.15B | -0.0% | — |
| Total Liabilities | $2.13B | -2.6% | — |
| Stockholders' Equity | $1.57B | -4.2% | -59.3% |